SS-31 (Elamipretide): Exploring the Science of Mitochondrial Peptide Research

SS-31, also known as elamipretide, is a mitochondria-targeted tetrapeptide that has attracted significant scientific interest for its ability to interact with cardiolipin, a specialised phospholipid found predominantly within the inner mitochondrial membrane.

Mitochondria are responsible for producing much of the cellular energy required to support normal biological function. Because mitochondrial dysfunction is associated with numerous diseases and biological processes, researchers have increasingly investigated compounds capable of interacting directly with mitochondrial membranes.

SS-31 is one of the most extensively investigated peptides in this field and has progressed from preclinical mitochondrial research into human clinical trials.

What Is SS-31?

SS-31 belongs to the Szeto-Schiller (SS) family of mitochondria-targeted peptides.

The compound is also known by several names, including:

• SS-31
• Elamipretide
• MTP-131
• Bendavia

It is a small, cell-permeable tetrapeptide with an alternating aromatic-cationic structure. Unlike many peptides that act primarily on receptors located at the cell surface, SS-31 has been specifically designed to reach mitochondria and interact with mitochondrial membranes.

A major research focus has been its interaction with cardiolipin, an unusual phospholipid that plays an important role in maintaining the structure and function of the inner mitochondrial membrane.

Understanding Mitochondria

Mitochondria are often described as the "powerhouses" of cells because they play a central role in generating adenosine triphosphate (ATP) through oxidative phosphorylation.

However, their role extends well beyond energy production. Mitochondria are involved in:

• Cellular energy metabolism
• Reactive oxygen species signalling
• Calcium regulation
• Apoptotic signalling
• Maintenance of cellular homeostasis
• Regulation of metabolic pathways

The inner mitochondrial membrane contains cardiolipin, which helps organise proteins involved in the electron transport chain and contributes to the structural organisation of mitochondrial cristae. Disruption of cardiolipin composition or mitochondrial membrane organisation can interfere with normal mitochondrial function.

This relationship between cardiolipin and mitochondrial function is one of the reasons SS-31 has become an important research compound.

How Does SS-31 Work?

SS-31 is attracted to mitochondrial membranes through interactions involving both electrostatic and hydrophobic forces.

Research indicates that the peptide preferentially interacts with cardiolipin within the mitochondrial membrane. Rather than simply accumulating inside mitochondria, SS-31 appears to interact directly with the membrane environment and influence its physical properties.

Laboratory research has shown that SS-31 can alter membrane surface electrostatics and influence the distribution of ions, including calcium, at the membrane interface.

These findings have led researchers to investigate whether SS-31 can help maintain mitochondrial membrane organisation and support mitochondrial bioenergetics under conditions of cellular stress.

SS-31 and Cardiolipin

Cardiolipin is central to understanding SS-31.

Unlike many phospholipids found throughout cellular membranes, cardiolipin is highly concentrated within the inner mitochondrial membrane.

It contributes to the organisation and stability of respiratory-chain protein complexes and helps maintain the architecture of mitochondrial cristae.

SS-31's affinity for cardiolipin gives researchers a mechanism for targeting mitochondrial membrane biology directly.

Experimental studies have demonstrated that SS-31 binds lipid membranes in a concentration- and charge-dependent manner without destabilising the membrane structure. Researchers have proposed that changes in membrane electrostatics and lipid organisation may contribute to its mitochondrial effects.

SS-31 and Mitochondrial Energy Production

One of the major areas of SS-31 research involves mitochondrial bioenergetics.

Efficient ATP production depends on the coordinated function of the electron transport chain and oxidative phosphorylation. The proteins involved in these processes are embedded within the inner mitochondrial membrane, where cardiolipin helps maintain their organisation.

Preclinical research has therefore investigated whether SS-31 can influence mitochondrial efficiency under conditions associated with oxidative or metabolic stress.

Research in cardiac models has reported effects on mitochondrial function, while laboratory studies have provided evidence supporting interactions between SS-31, cardiolipin and mitochondrial membrane organisation.

Importantly, these mechanisms should not be interpreted as evidence that SS-31 automatically increases energy or performance in healthy individuals. Much of the research concerns specific disease models or experimentally induced mitochondrial dysfunction.

SS-31 and Oxidative Stress

Mitochondrial dysfunction can be associated with increased production of reactive oxygen species (ROS).

Excessive oxidative stress can affect mitochondrial proteins, lipids and DNA, potentially creating a cycle in which damaged mitochondria become less efficient.

Preclinical studies have investigated SS-31 in models of mitochondrial dysfunction and oxidative stress, with findings suggesting potential mitochondrial-protective effects. These results have contributed to interest in SS-31 as a research tool for understanding mitochondrial resilience.

However, evidence from animal and laboratory studies cannot automatically be translated into proven benefits for healthy humans.

Human Clinical Research

SS-31 has progressed beyond laboratory research and has been evaluated in human clinical trials.

One notable area of research has been Barth syndrome, a rare genetic disorder involving abnormalities in cardiolipin metabolism and mitochondrial function.

In a Phase 2/3 study, researchers evaluated elamipretide in individuals with genetically confirmed Barth syndrome. The initial crossover portion of the trial did not meet its primary endpoints, although improvements were observed in certain measures during the subsequent open-label extension.

Research has also examined elamipretide in cardiovascular and other mitochondrial conditions, helping scientists better understand how mitochondria-targeted therapies may influence human physiology.

The clinical evidence is therefore more substantial than for many experimental peptides, but results vary according to the disease and study design.

Potential Research Applications

Because of its mitochondrial targeting properties, SS-31 has been investigated across several areas of biomedical research.

Mitochondrial Dysfunction

Researchers use SS-31 to investigate mechanisms underlying impaired mitochondrial function and cellular bioenergetics.

Cardiovascular Research

The heart has exceptionally high energy requirements, making mitochondrial function particularly important. SS-31 has therefore been investigated in models of cardiac mitochondrial dysfunction and heart failure.

Rare Mitochondrial Diseases

Barth syndrome has been an important clinical research area because of its direct connection to abnormal cardiolipin metabolism.

Cellular Bioenergetics

SS-31 provides researchers with a tool for studying relationships between mitochondrial membranes, electron transport, oxidative phosphorylation and cellular energy metabolism.

Mitochondrial Membrane Biology

Because SS-31 interacts directly with cardiolipin-containing membranes, it is also valuable for investigating membrane structure, lipid organisation and mitochondrial signalling.

SS-31 vs Other Peptides

SS-31 differs substantially from many of the peptides commonly discussed in research environments.

Rather than primarily targeting growth hormone secretion, melanocortin receptors or tissue-repair pathways, SS-31 is designed around mitochondrial targeting.

Its defining characteristic is its interaction with the mitochondrial inner membrane and cardiolipin.

This makes SS-31 particularly interesting for researchers studying mitochondrial biology rather than conventional peptide-receptor pharmacology.

Why Is SS-31 Generating Interest?

Interest in SS-31 has grown because mitochondrial dysfunction is increasingly recognised as an important component of many biological processes and disease states.

The ability to investigate a peptide that specifically interacts with mitochondrial membranes provides researchers with an opportunity to study mitochondrial biology from a different perspective.

Rather than attempting to increase cellular energy production indirectly, SS-31 research focuses on the underlying mitochondrial membrane environment that supports oxidative phosphorylation and cellular bioenergetics.

That distinction is important when evaluating claims surrounding mitochondrial peptides.

SS-31 10mg Research Peptide

SS-31 10mg is supplied as a research peptide intended for laboratory and scientific research applications.

Researchers investigating SS-31 may use the compound to study:

• Mitochondrial membrane biology
• Cardiolipin interactions
• Cellular bioenergetics
• Oxidative stress
• Mitochondrial dysfunction
• Electron transport and oxidative phosphorylation
• Cardiovascular mitochondrial function
• Peptide-membrane interactions

As with other biologically active research compounds, appropriate laboratory procedures, validated analytical methods and relevant safety protocols should be followed.

Final Thoughts

SS-31, or elamipretide, represents a unique class of mitochondrial-targeted peptide research.

Its ability to interact with cardiolipin within the inner mitochondrial membrane distinguishes it from many other experimental peptides and provides researchers with a powerful tool for investigating mitochondrial structure, membrane biology and cellular bioenergetics.

Although preclinical and clinical research has produced interesting findings, it is important to distinguish experimental evidence from established therapeutic outcomes. Research into SS-31 continues to explore how mitochondrial-targeted peptides may influence cellular function across different biological and disease models.

SS-31 10mg is intended for research purposes only and is not intended for human consumption or self-administration.

This article is provided for educational and research-information purposes only. It does not constitute medical advice, diagnosis or treatment guidance.

References

• Mitchell TW, et al. The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action.
• Thompson WR, et al. A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome.
• Elamipretide Improves Mitochondrial Function in the Failing Human Heart.
• Elamipretide and cardiolipin: mitochondrial-targeted peptide research in Barth syndrome.